US4332795A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Inflammation-preventing pharmaceutical composition of oral administration
Assignee: A Natterman und Cie GmbH
•
Filing: 1979-12-17
•
Granted: 1982-06-01
•
Expires: 1999-12-17
Abstract
Abstract A novel pharmaceutical composition is provided which is suitable for the prevention of inflammation and which comprises non-steroidal inflammation-preventing compound (e.g. pyrazolones, salicylic acid derivatives, indoles, indanes, and phenylacetic acid and anthranilic acid derivatives) and at least one phospholipid.
Inventors
- 👤 Miklos Ghyczy
- 👤 Adorjan Erdos
- 👤 Gunter Heidemann
- 👤 Gotz Ritzmann
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:49
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66; A61K31/683; A61K31/685; A61K47/00; A61K47/06; A61K47/24; A61K9/00; A61K9/20; A61K9/2004; A61K9/2013; A61K9/48; A61K9/4841; A61K9/4858; A61P; A61P29/00
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
42 words
A method of alleviating inflammation in a mammal comprising orally administering to said mammal an effective inflammation-alleviating amount of a pharmaceutical composition comprising a phospholipid and a non-steroidal inflammation-preventing indole in a molar ratio ranging from about 0.1:1 to about 20:1, respectively.
Claim 2
Independent Claim
42 words
A method of alleviating inflammation in a mammal comprising orally administering to said mammal an effective inflammation-alleviating amount of a pharmaceutical composition comprising a phospholipid and a non-steroidal inflammation-preventing indole in a molar ratio ranging from about 0.1:1 to about 20:1, respectively.
Claim 3
Dependent Claim
19 words
The method of claim 1 wherein said indole is selected from the group consisting of indometacine, glucametacine, and acemetacine.
Claim 4
Dependent Claim
10 words
The method of claim 2 wherein said indole is indometacine.
Claim 5
Dependent Claim
10 words
The method of claim 2 wherein said indole is acemetacine.
Claim 6
Dependent Claim
23 words
The method of claim 1 wherein said phospholipid and said indole are present in molar ratios ranging from about 0.5:1 to about 2:1.
Claim 7
Dependent Claim
10 words
The method of claim 1 wherein said phospholipid is phosphatidylcholine.
Claim 8
Dependent Claim
10 words
The method of claim 1 wherein said phospholipid is phosphatidylinositol.
Claim 9
Dependent Claim
41 words
A pharmaceutical composition in a form for oral administration in the prevention of inflammation in mammals comprising an effective inflammation-alleviating amount of a phospholipid and a non-steroidal inflammation-preventing indole in a molar ratio ranging from about 0.1:1 to about 20:1, respectively.
Claim 10
Dependent Claim
41 words
A pharmaceutical composition in a form for oral administration in the prevention of inflammation in mammals comprising an effective inflammation-alleviating amount of a phospholipid and a non-steroidal inflammation-preventing indole in a molar ratio ranging from about 0.1:1 to about 20:1, respectively.
Claim 11
Dependent Claim
20 words
The pharmaceutical composition of claim 8, wherein said indole is selected from the group consisting of indometacine, glucametacine, and acemetacine.
Claim 12
Dependent Claim
11 words
The pharmaceutical composition of claim 9 wherein said indole is indometacine.
Claim 13
Dependent Claim
11 words
The pharmaceutical composition of claim 9 wherein said indole is acemetacine.
Claim 14
Dependent Claim
24 words
The pharmaceutical composition of claim 8 wherein said phospholipid and said indole are present in molar ratios ranging from about 0.5:1 to about 2:1.
Claim 15
Dependent Claim
11 words
The pharmaceutical composition of claim 8 wherein said phospholipid is phosphatidylchloine.
Claim 16
Dependent Claim
11 words
The pharmaceutical composition of claim 8 wherein said phospholipid is phosphatidylinositol.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-05-31 | 1985-11-30 | 1986-06-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-05-31 | 1989-11-30 | 1990-06-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-05-31 | 1993-11-30 | 1994-06-01 | $7700.00 | Window Closed / Lapsed |